key: cord-1014705-kyo2hi9u authors: nan title: Fatal Pulmonary Thromboembolism in SARS-CoV-2-Infection date: 2020-10-31 journal: Cardiovascular Pathology DOI: 10.1016/j.carpath.2020.107227 sha: 99f8b1f3cdbfa5386aa278fc93f66dcdf88a5ec5 doc_id: 1014705 cord_uid: kyo2hi9u nan Pandemic spread of the novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the new disease Coronavirus disease 2019 (COVID-19), has been associated with a case fatality rate of 2.3% [1] , approaching the > 2.5% rate estimated for the 1918 Influenza pandemic [2] . However, information regarding the precise cause of death in patients expiring with COVID-19 has been limited. We report the finding of pulmonary thromboembolism as the cause of death in the initial two COVID-19 patients examined postmortem at our institution. The first patient, a middle-aged male with well-controlled hypertension, was admitted with nine days of fever, chills, myalgia, dry cough, and dyspnea. On examination, he was found to have a temperature of 39.4 0 C and SpO2 of 92% on room air. A nasopharyngeal swab was positive for SARS-CoV-2 by realtime reverse-transcription-polymerase-chain-reaction amplification for both the SARS-CoV-2 ORF1 a/b and pan-Sarbecovirus E-gene (RT-PCR, cobas R 6800 system, RocheDiagnostics), but the initial chest radiograph showed only mild bilateral pulmonary vascular congestion. He was treated with ceftriaxone and azithromycin for presumed bacterial superinfection with improvement in fever and leukocytosis, but continued to require supplemental nasal oxygen. The serum inflammatory markers ferritin (752 ng/ml, reference range 30-400ng/ml) and C-reactive protein (43.74 mg/L, reference range < 5.1 mg/L) were noted to be elevated. Repeat chest radiograph on hospital day 8 revealed new dense patchy left mid-lung and retrocardiac opacities, and a hazy opacity in the right lower lung. On day 9, the patient complained of increasing left inspira-tory chest pain and tenderness; 30 minutes later the patient was found to have pulseless electrical activity. The second, a middle-aged male with asthma, hypertension and human immunodeficiency virus infection controlled on highlyactive antiretroviral therapy, was admitted with fever, chills, productive cough and dyspnea worsening over 2 days. A nasopharyngeal swab obtained during an evaluation the previous day was positive for SARS-CoV-2 by the Roche cobas R 6800 RT-PCR assay. Examination at admission was notable for a temperature of 38.4 0 C and SpO2 of 93% on room air; multiple bilateral lung opacities were noted on chest radiography. Elevated serum ferritin (411 ng/ml) and C-reactive protein (271.6 mg/L) were noted, and these values continued to rise despite treatment with broad-spectrum antibiotics. Of note, prothrombin time/INR was measured on multiple days and was not prolonged. His condition deteriorated, requiring intubation and ventilator support; over the next 3 days he became hemodynamically unstable requiring multiple pressors. Eight days following admission he developed pulseless electrical activity. At autopsy, a common notable finding was pulmonary thromboembolism, with occlusion of the right main pulmonary artery in one case, and occlusion of both left and right main pulmonary arteries in the second ( Fig. 1 A-B) . Deep venous thrombosis was found in both cases. Other findings in both cases were multiple foci of pulmonary parenchymal firmness consistent with bilateral pulmonary consolidation, cardiomegaly, and left ventricular hypertrophy consistent with hypertensive cardiovascular disease. Histological examination of the lungs revealed characteristic pale pink and red areas (Zhan lines) representing alternating strata of platelets and fibrin with admixed layers of erythrocytes, consistent with pulmonary thromboembolism ( Fig. 1 C-D) . Ultrastructural examination demonstrated pleomorphic virallike particles ranging from 60 to 120 nm in distended cytoplasmic https://doi.org/10.1016/j.carpath.2020.107227 1054-8807 vacuoles within the pneumocytes in lung specimens from both cases ( Fig. 2 A-B) . Rupture of the cytoplasmic vacuoles with release of the virus-like particles into the alveolar lumen is shown in Fig. 2 A. The individual spherical viral-like particles display distinctive projections with mature particles exhibiting electron dense centers, consistent with the appearance of coronavirus ( Fig. 2 B) . Fibrin deposition within and outside capillaries ( Fig. 2 C-D), as well as pure platelet thrombi was also noted ( Fig. 2 E-F) . In contrast to the majority of patients with SARS-CoV-2 infection, who are asymptomatic or pauci-symptomatic, some patients will develop severe illness progressing to acute respiratory distress syndrome (ARDS), followed by death in a significant subset [3] . Recent reports from the People's Republic of China have associated severe pneumonia and fatal outcomes in SARS CoV-2 with elevated levels of D-dimer and fibrin degradation products (FDP), suggesting derangement of coagulation activation and consequently a potential for predisposition to thromboembolic events [4 , 5] . Notably, several viral infections have been associated with coagulation disorders that may lead to thrombosis and disseminated intravascular coagulation [6] , including influenza virus and SARS which have been associated with pulmonary intravascular thrombi formation and fibrin deposition likely as a result of disseminated intravascular coagulation and microthrombosis [7 , 8] . In SARS coronavirus infection, increased production of a novel procoagulant by infected cells due to increased hfg12 gene transcription induced by viral nucleocapsid (N) protein has been proposed as mechanism contributing to thrombosis [9] . As reported previously for SARS-CoV [10] , our findings suggest that SARS-CoV-2 infected patients similarly may be at increased risk for pulmonary thromboembolic events, due to a baseline hypercoagulable state, and may benefit from evaluation and management for coagulopathy early in the course of disease. Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China Influenza: the mother of all pandemics Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Prominent changes in blood coagulation of patients with SARS-CoV-2 infection Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 Review: Viral infections and mechanisms of thrombosis and bleeding Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens Pulmonary pathology of severe acute respiratory syndrome in Toronto The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome The authors thank Carlos Cordon-Cardo MD, PhD for his consistent encouragement and support.